280818-245.jpg_thumb90

Pablo Andrés Sepúlveda Varela

Cardiólogo Intervencionista

Pontificia Universidad Católica de Chile

Santiago, Chile

Líneas de Investigación


Interventional cardiology; Clinical cardiology; Clinical trials; Acute coronary syndromes; Pulmonary hypertension; Pulmonary embolism; Heart failure; Cardiovascular molecular biology; Genetic Polymorphism.

Educación

  •  MEDICO CIRUJANO, UNIVERSIDAD DE CHILE. Chile, 1996
  •  MEDICINA INTERNA, UNIVERSIDAD DE CHILE. Chile, 1999
  •  CARDIOLOGIA, Hospital San Juan de Dios. Chile, 2000
  •  CARDIOLOGIA INTERVENCIONAL, Clinique Saint Jean. Bélgica, 2001

Experiencia Académica

  •   PROFESOR AUXILIAR Part Time

    UNIVERSIDAD DE LOS ANDES

    MEDICINA

    Santiago, Chile

    2006 - 2008

  •   PROFESOR ASISTENTE Part Time

    UNIVERSIDAD DE CHILE

    MEDICINA

    Santiago, Chile

    2015 - 2018

  •   PROFESOR ASISTENTE Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    MEDICINA

    Santiago, Chile

    2018 - At present

Experiencia Profesional

  •   Interventional Cardiologist / Head PAH Clinic Part Time

    Hospital San Juan de Dios

    Santiago, Chile

    2001 - 2018

  •   CCU Resident / Interventional Cardiologist Part Time

    Clínica Dávila

    Santiago, Chile

    2001 - 2007

  •   Chief CCU / Interventional Cardiologist Part Time

    Clínica Tabancura

    Santiago, Chile

    2007 - 2016

  •   Interventional Cardiologist Other

    Clínica Las Condes

    Santiago, Chile

    2016 - 2018


 

Article (27)

Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension A Double-Blind Placebo-controlled Clinical Trial
Combination therapy with oral treprostinil for pulmonary arterial hypertension. A double-blind placebo-controlled clinical trial.
Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension
Reperfusión fármaco-invasiva en el manejo del infarto agudo del miocardio en Chile: Un llamado a la acción.
TREATMENT BENEFITS ASSOCIATED WITH OPEN LABEL ORAL TREPROSTINIL AFTER CLINICAL WORSENING IN THE PHASE 3 FREEDOM-EV STUDY FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
Exceso de mortalidad no cardíaca en pacientes sometidos a angioplastía de puentes coronarios
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
Acute effect of iloprost inhalation on right atrial function and ventricular dyssynchrony in patients with pulmonary artery hypertension
Characteristics, management, and outcomes of illicit drug consumers with acute myocardial infarction
Effect of educational level on the prognosis of acute myocardial infarction
Effect of educational level on the prognosis of acute myocardial infarction [Efecto del nivel educacional en la sobrevida posterior a un infarto agudo de miocardio: Registro Chileno de Infarto de Miocardio, GEMI 2009-2012]
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Prevalence of seven cardiovascular-related genetic polymorphisms in a Chilean mestizo healthy population
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo
Effects of Trimetazidine in Nonischemic Heart Failure: A Randomized Study
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
Relationship between mechanical and metabolic dyssynchrony with left bundle branch block: Evaluation by 18-fluorodeoxyglucose positron emission tomography in patients with non-ischemic heart failure
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
Cambios en el pronóstico a largo plazo de la hipertensión arterial pulmonar
Changes long term prognosis of 17 patients with pulmonary artery hypertension
Chilean results of the international registry of risk factors and treatment of unstable angina and non ST elevation myocardial infarction: ACCORD (ACute CORonary syndrome Descriptive study)
Resultados Chilenos del registro internacional de factores de riesgo y tratamiento de angina inestable e infarto al miocardio sin supradesnivel del segmento ST: ACCORD (ACute CORonary syndrome Descriptive study)
Valvuloplastía mitral percutánea: experiencia del Hospital San Juan de Dios
Percutaneous mitral balloon valvotomy: Six-year follow-up
Características clínicas y tratamiento de pacientes con infarto agudodel miocardio con supradesnivel st y shock cardiogénico: 9 años del Registro GEMI

Abstract (8)

Dose-response relationship of oral treprostinil for secondary endpoints in the FREEDOM-EV study
Treatment with Oral Treprostinil Delays Time to Clinical Worsening in Patients with Pulmonary Arterial Hypertension - Results from FREEDOM-EV
Acute changes in right atrial function after iloprost inhalation in patients with pulmonary arterial hypertension: an echocardiographic deformation imaging study
Acute changes in right ventricular synchrony and function post inhaled iloprost in pulmonary artery hypertension patients: a myocardial deformation imaging study
Long term survival after acute myocardial infarction according to attained education level in the Chilean AMI Register, GEMI 2009-2012
Differences in treatment and in-hospital mortality of acute myocardial infarction patients in public and private hospitals in Chile before and after healthcare guarantees
Increased Oxidative Stress Correlates With Pulmonary Vascular Response to Vasodilators in Pulmonary Artery Hypertension Patients
Ambulatory radial coronary angioplasty: Is it a feasible approach?

BookSection (2)

Tromboembolismo Pulmonar
Paro Cardiorespiratorio
37
Pablo Sepúlveda

Cardiólogo Intervencionista

División de Enfermedades Cardiovasculares

Pontificia Universidad Católica de Chile

Santiago, Chile

5
Carolina Nazzal

Profesor Asociado

Instituto de Salud Poblacional

Universidad de Chile

Santiago, Chile

4
Douglas Greig

Médico Jefe

Cardiología

P. Universidad Católica de Chile

Santiago, Chile

4
Hugo Verdejo

Profesor Asociado

División de Enferemedades Cardiovasculares

Pontificia Universidad Católica de Chile

Santiago, Chile

4
Ramon Corbalan

Director

Division of Cardiovascular Diseases

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

SANTIAGO, Chile

3
SERGIO LAVANDERO

Director

Advanced Center for Chronic Diseases (ACCDiS)

UNIVERSIDAD DE CHILE, FAC CIENCIAS QUÍMICAS Y FARMACÉUTICAS

Santiago, Chile

3
Mario Chiong

Profesor

Departamento de Bioquímica y Biología Molecular

Universidad de Chile

Santiago, Chile

2
Luigi Gabrielli

Profesor Asistente

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Chile

2
Juan Prieto

Profesor Titular

Programa de Farmacología Molecular y Clínica

Universidad de Chile

Santiago, Chile

2
Fernando Lanas

Profesor titular

Medicina Interna

UNIVERSIDAD DE LA FRONTERA

Temuco, Chile

1
Luis Quinones

PROFESOR TITULAR

ONCOLOGIA BASICO-CLINICA

UNIVERSIDAD DE CHILE

Santiago, Chile

1
JORGE JALIL

FULL PROFESSOR

ENFS CARDIOVASCULARES

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE, ESCUELA DE MEDICINA

Santiago, Chile

1
Juan Carlos Quintana

Médico nuclear

Radiología

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

1
Rosemarie Mellado

Jefe de carrera / Académica

Farmacia

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

1
Maria Ocaranza

Asociate Professor

Cardiovascular Diseases Division

Pontificia Universidad Catolica de Chile

Santiago, Chile

1
Laura Huidobro

Encargada Investigación

Ciencias Preclínicas

Universidad Católica del Maule

Talca, Chile

1
Lorena Garcia

Assistant Professor

Bioquimica y Biologia Molecular

UNIVERSIDAD DE CHILE

Santiago, Chile

1
Pablo Castro

JEFE DIVISION

DIVISION ENFERMEDADES CARDIOVASCULARES

Pontificia Universidad Católica de Chile

SANTIAGO, Chile

1
Angel Puentes

Jefe

Servicio de Cardiología

Hospital San Juan de Dios

Santiago, Chile

1
MONICA ZAGOLIN

COORDINADOR PROGRAMA

DOCENCIA Y MEDICINA

INSTITUTO DEL TORAX

santiago, Chile